prof. Eva Van Braeckel

Cystic fibrosis as a modulable model for CFTR-related Immune dysregulation

Leander Jonckheere (UGent) , Cedric Bosteels (UGent) , Iris Janssens (UGent) , Sebastian Riemann (UGent) , Lieve Vande Sande, Tania Maes (UGent) , Yannick Vande Weygaerde (UGent) , Stephanie Van Biervliet (UGent) , Filomeen Haerynck (UGent) , Bart Lambrecht (UGent) , et al.

(2025) AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. In American Journal of Respiratory and Critical Care Medicine 211(Supplement S).

Add to list

Journal Article
A1
open access

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103) : results from two randomised, active-controlled, phase 3 trials

Claire Keating, Lael M Yonker, François Vermeulen, Dario Prais, Rachel W Linnemann, Aaron Trimble, Tom Kotsimbos, Joel Mermis, Andrew T Braun, Mark O'Carroll, et al.

(2025) LANCET RESPIRATORY MEDICINE. 13(3). p.256-271

Add to list

Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

James D. Chalmers, Pierre-Régis Burgel, Charles L. Daley, Anthony De Soyza, Charles S. Haworth, David Mauger, Michael R. Loebinger, Pamela J. McShane, Felix C. Ringshausen, Francesco Blasi, et al.

(2025) NEW ENGLAND JOURNAL OF MEDICINE. 392(16). p.1569-1581

Add to list

Journal Article
A1
open access

Use of inhaled corticosteroids in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)

Jennifer Pollock, Eva Polverino, Raja Dhar, Katerina Dimakou, Letizia Traversi, Apostolos Bossios, Charles Haworth, Michael R Loebinger, Anthony De Soyza, Montserrat Vendrell, et al.

(2025) THORAX. 80(6). p.358-368

Add to list

Journal Article
A1
open access

Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus

Eliane Vanhoffelen, Tine Van Win, Eva Van Braeckel (UGent) , Agustin Reséndiz-Sharpe, Bruno P.A. Cammue, Katrien Lagrou (UGent) , Karin Thevissen and Greetje Vande Velde

(2025) FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 15.

Add to list

Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients

Evi Duthoo (UGent) , Elien Beyls (UGent) , Lynn Backers (UGent) , Thorkell Gudjónsson, Peiquan Huang, Leander Jonckheere (UGent) , Sebastian Riemann (UGent) , Bram Parton (UGent) , Likun Du, Veronique Debacker (UGent) , et al.

(2025) JOURNAL OF EXPERIMENTAL MEDICINE. 222(5).

Add to list

Journal Article
A1
open access

Healthcare worker views on antimicrobial resistance in chronic respiratory disease

Sachin Ananth, Adekunle O Adeoti, Animesh Ray, Peter G Middleton, Miquel Ekkelenkamp, Stephanie Thee, Anand Shah, Eva Van Braeckel (UGent) , Yannick Vande Weygaerde (UGent) and [missing] AMR-Lung Clinical Res Collaboration

(2025) ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL. 14(1).

Add to list

Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis

Senne Cuyx, Anabela Santo Ramalho, Steffen Fieuws, Nikky Corthout, Marijke Proesmans, Mieke Boon, Kaline Arnauts, Marianne S Carlon, Sebastian Munck, Lieven Dupont, et al.

(2024) THORAX. 79(9). p.834-841

Add to list

Cystic fibrosis and the role of CFTR in circulating immune cells : a human single-cell atlas

Leander Jonckheere (UGent) , Cedric Bosteels (UGent) , Iris Janssens (UGent) , Yannick Vande Weygaerde (UGent) , Tania Maes (UGent) , Robin Browaeys (UGent) , Niels Vandamme (UGent) , Simon Tavernier (UGent) , Bart Lambrecht (UGent) and Eva Van Braeckel (UGent)

(2024) EUROPEAN RESPIRATORY JOURNAL. In European Respiratory Journal 64(Supplement 68).

Add to list

Modulation is not an independent determinant of the viscoelastic properties of sputum in cystic fibrosis

Iris Janssens (UGent) , Leander Jonckheere (UGent) , Helena Catharine Aegerter (UGent) , M. De Coninck, Yannick Vande Weygaerde (UGent) , Bart Lambrecht (UGent) and Eva Van Braeckel (UGent)

(2024) JOURNAL OF CYSTIC FIBROSIS. In Journal of Cystic Fibrosis 23(Supplement 1). p.S53-S53

Academic Bibliography

prof. Eva Van Braeckel

Cystic fibrosis as a modulable model for CFTR-related Immune dysregulation

Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103) : results from two randomised, active-controlled, phase 3 trials

Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis

Use of inhaled corticosteroids in bronchiectasis : data from the European Bronchiectasis Registry (EMBARC)

Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus

Replication stress, microcephalic primordial dwarfism, and compromised immunity in ATRIP deficient patients

Healthcare worker views on antimicrobial resistance in chronic respiratory disease

Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis

Cystic fibrosis and the role of CFTR in circulating immune cells : a human single-cell atlas

Modulation is not an independent determinant of the viscoelastic properties of sputum in cystic fibrosis

Contents

Support

Contact